Supplement for "Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study"

Supplementary Information and Results - Nakagawa H, et al. Delgocitinib ointment in pediatric patients with atopic dermatitis: a phase 3, randomized, double-blind, vehicle-controlled study and a subsequent open-label, long-term study. Change in Version 2: - Correction of the values of "Expose duration" in Supplementary Table I补充信息与结果——中川H（Nakagawa H）等人：《地洛吉替尼（delgocitinib）软膏治疗儿童特应性皮炎（atopic dermatitis）：一项3期（phase 3）随机双盲赋形剂对照（vehicle-controlled）研究及后续开放标签长期研究》 版本2更新内容：- 更正补充表I（Supplementary Table I）中"暴露时长"的数值